#Paediatric Medical Device Market

[meditech-insights]

Global Digital Behavioral/Mental Health Market is projected to grow at a CAGR of 25% by 2026

In recent years, the healthcare industry has observed the foray of several providers that offer software for behavioral and mental health practices: EHR, teletherapy, scheduling, client engagement, billing, and digital therapeutics to prevent, manage and treat medical disorders.

The Global Digital Behavioral/Mental Health Market is set to witness an exponential growth rate of 25% in the next 5 years. Some of the key factors influencing the global digital behavioral/mental health market include Covid-19, the rising burden of mental disorders worldwide, the penetration of personal digital devices, a favorable funding environment, and growing healthcare IT infrastructure in developed and developing. However, concerns related to patient privacy and the shortage of HCIT professionals are likely to hamper the growth of the market.

Demand for Digital Behavioral/Mental Health Market Solutions Surge Amid Covid-19

With lockdowns implemented, social distancing mandated, and widespread apprehension; as a result, Covid-19 dramatically increased the burden of managed healthcare, particularly for the treatment of neurological and psychiatric diseases.

The widespread use of personal digital devices like smartphones, fitness trackers, tablets, and the launch of digital solutions ensured that the digital mental health tools were accessed more frequently and by a wider demographic of patients. Benefits such as therapeutic approaches to support positive behavioral change on a large scale, anywhere, anytime accessibility, on-demand help without waiting lines, convenience, and ease of use were the key factors that fueled its demand.

Digital Behavioral/Mental Health Tools for Children and Teens Set to Open New Growth Avenues

The mental well-being of children and teenagers has been an area of concern given there are few pediatric mental health specialists in both developed and developing economies Long wait times for care and an increasing number of children being sent to the emergency room during mental health crisis situations has been a long-standing issue. Several digital health companies have entered the market to address these worries.

For instance,

In March 2022, Brightline, a leader in virtual behavioral health care for children, adolescents, and families, secured a $105M Series C funding. Brightline offers a digital on-demand platform, Connect, along with its coaching programs and clinical services including behavioral therapy, evaluation, medication support, and speech therapy

“A limited number of paediatric mental health specialists has been a persistent issue in the United States. Virtual health care exploded during the Covid-19 pandemic and this further exacerbated the mental health crisis situation among the children and youth. As a result, several companies are now targeting the behavioral health needs of children and teenagers.”- Senior Director, Virtual Behavioral Health Care Provider, United States

Explore Premium Report on Digital Behavioral/Mental Health Market @ https://meditechinsights.com/digital-behavioral-mental-health-market/

Organic and Inorganic Growth Strategies Adopted by Players to Establish Their Foothold in Digital Behavioral/Mental Health Market

The global digital behavioral/mental health market is a developing but competitive market marked by the presence of both established and new players. Players operating in the market adopt both organic and inorganic growth strategies such as new product launches, and acquisitions to garner market share.

For instance,

In April 2022, Talkspace, the leading provider of virtual behavioral health services, launched new product suite - Talkspace Self-Guided, a suite of offerings for employers designed to help executives, managers, and teams prioritize and build emotional intelligence (EQ) and mental wellness in and out of the workplace

In Jan 2022, CloudMD Software & Services Inc. acquired MindBeacon Holdings Inc., one of North America’s leading providers of digital mental health care.

The digital behavioral/mental health market is a booming market that is anticipated to gain further momentum in the coming years due to the growing occurrence & awareness levels of mental health disorders, conducive funding environment, improving healthcare IT infrastructure, and aggressive organic and inorganic growth strategies followed by players.

Competitive Landscape Analysis of Digital Behavioral/Mental Health Market

The global digital behavioral/mental health market is marked by the presence of key players such as Akili, Pear Therapeutics, Advanced Data Systems, AdvancedMD, Credible, Lyra Health, Spring Health, Brightline, Little Otter, among others.

For More Detailed Insights, Contact Us @ https://meditechinsights.com/contact-us/

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

Contact:

Ruta Halde

Associate, Medi-Tech Insights

+32 498 86 80 79

info@meditechinsights.com 

[healthcarehubhh]

The brain health devices market will grow at highest pace owing to increasing awareness of brain related diseases and technological advancements in diagnostics devices

Brain health devices aid in the diagnosis and treatment of brain related disorders by leveraging technologies like electroencephalography (EEG), magnetoencephalography (MEG), transcranial magnetic stimulation (TMS), and intracranial pressure monitoring (ICP). These devices help understand patterns of neuronal activity, functional connectivity, and brain dynamics. The BrainScope Company's portable EEG device analyzes brain waves and classifies them to help diagnose brain injuries and concussions within minutes. Brain health devices are increasingly being used in hospitals, neuro laboratories and clinics to gain meaningful insights and devise personalized treatment plans for patients suffering from Alzheimer's, Parkinson's, epilepsy, strokes and dementia. The Global Brain Health Devices Market is estimated to be valued at US$ 9,070.5 million in 2024 and is expected to exhibit a CAGR of 7.7% over the forecast period 2023 to 2030. Key Takeaways Key players operating in the brain health devices market are BrainScope Company, Inc., Bio-Signal Group Corp., Cadwell Industries, Inc. Advanced Brain Monitoring, Inc., Compumedics Ltd., Elekta, DePuy Synthes, Electrical Geodesics, Inc., Medtronic, GE Healthcare, MEG International Services Ltd, Natus Medical, Inc., Neurowave Systems Inc., Nihon Kohden Corporation, and Philips Healthcare. Growing awareness regarding various brain related diseases and disorders is expected to propel the demand for brain health devices over the forecast period. Technological advancements are enabling high resolution scanning of brain structural and functional connectivity networks through lightweight and portable devices. Market Trends Portable and Home-Use Devices: Growing demand for convenient medical devices is prompting manufacturers to develop portable and wireless EEG, MEG, TMS and ICP monitoring equipment that can be used at home. This makes treatment accessible and inexpensive. Artificial Intelligence Integration: AI and machine learning techniques are finding widespread usage in brain data analysis. Devices are being integrated with AI capabilities to offer real-time diagnostics, automated report generation and personalized treatment recommendations. Market Opportunities Paediatric Applications: Brain monitoring and therapeutic devices tailored for infants and children can help diagnose developmental delays and disorders early. This presents lucrative opportunities. Emerging Markets: There is significant untapped growth potential in developing regions of Asia Pacific, Latin America, Middle East and Africa driven by rising healthcare expenditures and increasing incidence of neurological conditions. Impact of COVID-19 on Brain Health Devices Market The COVID-19 pandemic has accelerated the growth of the brain health devices market. Hospitals and diagnostic centers witnessed a surge in demand for brain monitoring devices due to the rising number of COVID-19 patients. Neurological complications were prevalent among severe COVID cases, necessitating effective brain monitoring. Further, risk factors of strokes and mental health issues increased amid lockdowns and social isolation, propelling the need for brain health management devices for diagnosis and treatment. The pandemic led to challenges in the supply chain and distribution channel initially. However, companies introduced new product lines specific to COVID care and virtually connected healthcare models utilizing brain health devices. The focus on portable, home-used devices for conditions like alzheimers, dementia, headaches, and insomnia aided market prospects. Telehealth emerged as an efficient mode to serve patients from remote locations as they avoided visits to crowded hospitals, especially during the peak pandemic periods.

[fairfield-research]

Microneedle Patches Market - Global Growth, Share, Trends, Demand and Analysis Report Forecast 2031

The global microneedle patches market is set to witness a remarkable surge, with forecasts indicating a trajectory towards reaching a substantial value of US$1600 billion by 2031, as reported in a comprehensive market analysis. The market, currently estimated at US$850 billion in 2024, is projected to exhibit a robust compound annual growth rate (CAGR) of 9.46% during the period spanning from 2024 to 2031.

For more information: https://www.fairfieldmarketresearch.com/report/microneedle-patches-market

Unveiling Market Dynamics:

Driving Forces:

Increasing Demand for Pain-Free Drug Delivery: Microneedle patches are emerging as a preferred choice for drug delivery, offering a minimally invasive and pain-free alternative to traditional injections. This trend is driven by a growing demand for patient-friendly medication administration methods, particularly among vulnerable demographics such as paediatric and geriatric populations.

Advancements in Drug Delivery Technologies: Ongoing innovations in microneedle patch technology, including the development of dissolvable and hollow microneedles, are facilitating precise delivery of a wide array of drugs, ranging from vaccines to insulin and biologics. These advancements enhance drug stability, bioavailability, and patient compliance, thus contributing significantly to market expansion.

Expanding Applications Across Healthcare Sectors: Microneedle patches are transcending traditional boundaries and finding applications beyond pharmaceuticals, extending into cosmetics, diagnostics, and monitoring. Their versatility in efficiently delivering various substances through the skin is attracting interest from diverse industries, driving significant market growth as new applications emerge and existing ones expand.

Challenges:

Regulatory Hurdles and Approval Processes: Stringent regulatory scrutiny and complex approval processes pose significant challenges to market players. Navigating through extensive testing, clinical trials, and regulatory submissions entails considerable time and resources, potentially leading to delays and increased costs.

Limited Penetration in Developing Regions: Inadequate healthcare infrastructure and resources in developing regions hinder the adoption of microneedle patches. Challenges related to access, affordability, and distribution networks further limit market penetration in underserved areas.

Concerns Regarding Efficacy and Safety: Despite technological advancements, concerns regarding the efficacy, safety, and long-term effects of microneedle patches persist among healthcare professionals and consumers. Addressing these concerns through robust clinical evidence and education initiatives is crucial to fostering trust and overcoming market restraints.

Key Trends and Opportunities:

Expansion of Applications: Microneedle patches are diversifying their applications beyond drug delivery, extending into cosmetics and diagnostics. This trend reflects the adaptability and versatility of microneedle technology, driving innovation and unlocking new market segments.

Integration of Smart Technologies: The integration of sensors and microelectronics into microneedle patches enables real-time monitoring and personalized treatment options, offering enhanced functionality and improved patient outcomes.

Expansion into Home Healthcare Market: There is a growing demand for convenient and user-friendly drug delivery devices in the home healthcare market. Microneedle patches, with their non-invasive and easy-to-use design, align well with this trend, presenting significant opportunities for market expansion.

Partnerships and Collaborations: Collaborative efforts with pharmaceutical companies, research institutions, and technology firms accelerate product development and commercialization, driving growth and competitiveness in the market.

Regional Insights:

North America: Leading the global market, North America benefits from high disposable incomes, a rapidly aging population, and a well-developed regulatory framework conducive to innovation.

Asia Pacific: The region presents a compelling picture of rapid market growth driven by rising disposable incomes, increasing awareness, and a large young population focused on personal appearance.

Europe: A mature market with significant growth potential, Europe boasts high healthcare expenditure, stringent safety regulations, and a strong presence of pharmaceutical and biotechnology companies.

Competitive Landscape:

The microneedle patches market features a mix of established companies and startups actively engaged in research, development, and strategic partnerships to enhance market presence and differentiate offerings. Key leaders in the space include 3M Company, Becton, Dickinson and Company, Nanopass Tech, among others, each contributing to market diversification across regions.

[pharmanucleus1]

Airway Management Devices Market: Revolutionizing Patient Care

According to a recent study report, the airway management devices market is predicted to generate $1.8 billion in revenue in 2022, growing to $2.4 billion by 2028. This equates to a compound annual growth rate (CAGR) of 5.6% between 2022 and 2028. The research looks at market purchasing patterns, price analysis, patent valuation, conference and webinar materials, and industry trends. Several factors are propelling market growth, including a rise in surgical procedures, an increase in the prevalence of chronic respiratory illnesses such as asthma and COPD, and an increase in demand for airway management devices in emerging economies.

Click here for full report:

https://www.pharmanucleus.com/reports/airway-management-devices-market

Airway Management Devices Market Dynamic

DRIVER: Rising incidence of pre-term births globally

Preterm birth occurs when a baby is born before the full 37 weeks of pregnancy. Premature births have recently become more common on a global scale. Babies who have trouble breathing may benefit from mechanical ventilation. These infants may also have breathing difficulties, apnea, asthma, and other respiratory abnormalities. Taking these factors into consideration, the growing prevalence of pre-term neonates promotes demand for airway management equipment. Vendors are offering items that satisfy the needs of newborns and paediatric patients in order to address the need for products that come in a variety of sizes and forms for airway control.

Click here for free sample report:

https://www.pharmanucleus.com/request-sample/1192

Restraint: Lack of reimbursement policies across emerging countries

Pricey airway management devices are rarely frequently utilised in emerging nations due to poor reimbursement systems or a lack of public health insurance coverage. Individuals are pushed to spend money they don't have because of ineffective policies and a lack of support for universal health care, which has a negative impact on the financial status of the poor throughout developing countries. Such circumstances have made a country more vulnerable to the threat of chronic diseases. Due to the high out-of-pocket costs of healthcare, the restricted adoption of costly medical devices such as video laryngoscopes and advanced surgical methods in developing countries has become a key market constraint.

OPPORTUNITY: Rising growth potential in developing countries

Market participants may anticipate future development opportunities from growing economies such as China, India, and Brazil. The primary motivation for development is because China and India have massive target patient populations. China's one-child policy has resulted in a considerable decrease in working-age population while increasing the elderly population. Furthermore, Malaysia and India have become important medical tourism hubs. Surgical procedures in these impoverished countries are substantially less expensive than in wealthier countries like the United States, Germany, France, and the United Kingdom. As the number of procedures grows, more airway management and anaesthetic treatments will be necessary.

Click here for free sample report:

https://www.pharmanucleus.com/request-sample/1192

CHALLENGE: Dearth of skilled professionals

Advanced training is required for airway management procedures such as cricothyrotomy, tracheostomy, and endotracheal intubation. Due to a lack of knowledge regarding the optimal course of urgent treatment, the patient's health may deteriorate, the recovery period may prolong, and direct and indirect expenditures may rise. A scarcity of anesthesiologists and paramedics is a big concern for governments all over the world. The paucity of airway management equipment used in these surgeries has further impacted the efficacy and ability of healthcare facilities to provide surgical and emergency treatment.

Click here for full report:

https://www.pharmanucleus.com/reports/airway-management-devices-market

Airway Management Devices Ecosystem

The airway management devices market is dominated by players such Medtronic (Ireland), ICU Medical

[rahulp3]

Breaking New Ground: Pediatric Obesity Management in 2033

The Global Pediatric Obesity Management Industry is reaching new heights, emerging as a paramount concern in public health. Recent data from the World Health Organization (WHO) reveals a staggering reality, with approximately 41 million children under the age of five identified as overweight or obese in 2016.

Alarming as it is, projections indicate a continued rise in these numbers in the years to come.Future Market Insights anticipates a transformative journey for the Pediatric Obesity Management Market, forecasting a compelling compound annual growth rate (CAGR) of 4% from 2023 to 2033. This projection underscores the urgency of addressing this global health challenge and highlights the significance of innovative solutions in pediatric obesity management.

Request a Sample of this Report Now! https://www.futuremarketinsights.com/reports/sample/rep-gb-16761

One of the most promising innovations in pediatric obesity management is the development of personalized nutrition and exercise plans. These plans take into account a child’s unique needs and preferences, as well as their medical history and any underlying conditions. By tailoring nutrition and exercise recommendations to each individual child, healthcare providers can help children achieve and maintain a healthy weight sustainably.

Another promising innovation is the use of digital health tools, such as mobile apps and wearable devices, to monitor and manage pediatric obesity. These tools can help children and their families track their progress, set goals, and receive personalized feedback and support. By making it easier and more convenient to manage pediatric obesity, digital health tools are helping to improve patient compliance and outcomes.Key Takeaways from the Global Pediatric Obesity Management Industry Study

The market for paediatric obesity management expanded at a CAGR of 3% between 2018 and 2022.From 2023 to 2033, the global market for paediatric obesity management is anticipated to expand at a 4% CAGR.The Pediatric Obesity Management Market is anticipated to generate US$4.74 billion by 2033.According to the FMI analysis, hospital pharmacies account for the largest market share.

In terms of market share for paediatric obesity management, North America is predicted to hold 40% of the market.With a share of 20% throughout the projection period, it is expected that the East & South Asia market would grow considerably.

[professionalutilities1]

What Is the Procedure for "CDSCO Registration for Paediatrics and Neonatology"?

The procedure for CDSCO (Central Drugs Standard Control Organization) registration for pediatrics and neonatology may involve several steps. However, please note that regulations and procedures may change, and it is essential to refer to the latest guidelines provided by CDSCO or consult with regulatory experts for the most current information. Here is a general overview based on the information available up to 2022:

Preparation and Documentation:

Gather all necessary documents, including the application form, product details, manufacturing information, quality control data, and clinical trial results (if applicable).

Submission of Application:

Submit the application for registration to the relevant CDSCO office, along with the required fees.

Review by CDSCO:

CDSCO will review the submitted documents to ensure compliance with regulatory requirements.

Inspection and Verification:

CDSCO may conduct inspections of manufacturing facilities to verify adherence to good manufacturing practices (GMP).

Approval or Rejection:

Based on the review and inspection, CDSCO will decide whether to grant approval for registration. If the application is in compliance, the product may be registered.

Post-Approval Compliance:

Maintain compliance with ongoing regulatory requirements, including periodic reporting and adherence to post-marketing surveillance.

It's crucial to note that the specific requirements and procedures may vary based on the type of product, its intended use, and the applicable regulations. Additionally, CDSCO may update its guidelines, so it's advisable to check the official CDSCO website or consult with regulatory experts for the most accurate and up-to-date information.

For precise and current guidance, consider reaching out to CDSCO directly or consulting with regulatory affairs professionals familiar with pharmaceutical and medical device registration in India.

[nexgenint]

Healthcare Market Research

Healthcare Research – (Healthcare Market Research)

With the invent of new products and services, the healthcare market research sector become more complex due to the high cost, intense competition, mediocre services provided by many players, growing dissatisfaction among patients. Now it is important for a service providers to render the services strategically. The success of a healthcare organization now relies primarily on competitive intelligence, market insights, in-depth knowledge, and strategic planning. Now healthcare market research becomes extremely important to succeed and win the heart of the patients. NexGen provides a range of healthcare market research services:Feasibility Study to start a healthcare facility like:•   Hospital •   Nursing home •   Day-care centre •   Imaging centre •   Path lab •   Dialysis centre •   Chemotherapy/radiotherapy centre •   Medical store Market Potential/Opportunities study for :•   Medical devices •   Hospital equipment •   Healthcare services (therapeutic areas/diseases) Doctors Studies•   Medical devices •   Oncologist •   Cardiologist •   Gastroenterologist •   Orthopaedics •   Obstetrics and Gynaecology •   Dermatology •   Paediatrics •   Ophthalmology •   General Physician •   Chest Medicine •   Anaesthesia •   ENT •   Diabetologist •   Pulmonologist •   Internal Medicine •   Radiology •   General Surgery •   Pathologist/Microbiologist Healthcare market research @NexGen

Primary Healthcare Market Research

NexGen conduct primary research using these methods:

•   Medical devices

•   Online Surveys

•   Face to face surveys

•   Telephonic surveys

•   In-depth interviews

•   Ethnographic research in healthcare settings

•   Focus Groups in Healthcare Settings

Secondary Healthcare Market Research

NexGen has expertise in conducting the secondary healthcare market research. Following are key sources to get the data:

•   Published market research reports

•   Consumer reports and industry reports

•   Healthcare provider websites

•   News, blogs and articles

•   Industry updates

[priyanshisingh]

Respiratory Inhaler Devices Market Global industry share, growth, drivers, emerging technologies, and forecast research report 2030

The latest market report published by Credence Research, Inc. “Global Respiratory Inhaler Devices Market: Growth, Future Prospects, and Competitive Analysis, 2016 – 2028. The global respiratory inhaler devices market has witnessed steady growth in recent years and is expected to grow at a CAGR of 17.50% between 2023 and 2030. The market was valued at USD 4.5 billion in 2022 and is expected to reach USD 13.91 billion in 2030.

Respiratory health and improving the lives of individuals suffering from respiratory conditions. In this press release, we proudly introduce our state-of-the-art respiratory inhaler devices that are poised to revolutionize the way people manage respiratory ailments. As a leading innovator in the medical device industry, we believe that our cutting-edge technology and dedication to patient care will not only help improve treatment outcomes but also elevate our website's ranking in Google searches.

The respiratory inhaler devices market is witnessing a surge in demand due to the current trends shaping the healthcare industry. One of the major factors driving this growth is the increasing prevalence of respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), worldwide. As more individuals are diagnosed with these conditions, there has been a growing need for effective and convenient treatment options. This has led to advancements in respiratory inhaler devices, with manufacturers focusing on developing innovative products that offer improved drug delivery mechanisms and user-friendly features.

Understanding the Respiratory Inhaler Devices Market

The respiratory inhaler devices market has witnessed significant growth over the years, driven by the rising prevalence of respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. These conditions affect millions worldwide, and the demand for effective inhaler devices has never been greater.

Our Revolutionary Respiratory Inhaler Devices

Our revolutionary respiratory inhaler devices stand at the forefront of medical technology, offering a myriad of benefits for patients and healthcare providers alike.

Cutting-Edge Technology

Our inhaler devices are equipped with cutting-edge technology, ensuring precise drug delivery to the lungs. The devices are designed to optimize drug dispersion, enhancing medication effectiveness and reducing potential side effects.

 User-Friendly Design

We understand the importance of ease-of-use for patients managing respiratory conditions. Our inhaler devices boast an ergonomic design, making them user-friendly for individuals of all ages. With simplified instructions, patients can administer medication effortlessly.

Smart Monitoring Capabilities

Incorporating smart monitoring capabilities, our inhaler devices allow patients and healthcare providers to track medication usage, adherence, and lung function over time. This data empowers healthcare professionals to tailor treatment plans for better patient outcomes.

Environmental Sustainability

Our commitment to the environment is reflected in the materials and manufacturing processes used for our inhaler devices. We prioritize sustainability, ensuring that our products have a minimal impact on the environment.

Browse 220 pages report Respiratory Inhaler Devices Market By Product Type (Dry Powder Inhaler, Metered Dose Inhaler, Soft Mist Inhaler, Others) By Patient (Adult, Paediatric)- Growth, Future Prospects & Competitive Analysis, 2016 – 2030)- https://www.credenceresearch.com/report/respiratory-inhaler-devices-market

The Competitive Edge

Superior Efficacy

Clinical trials and real-world studies have demonstrated the superior efficacy of our respiratory inhaler devices. Patients using our devices experienced improved symptom management and enhanced lung function, leading to an overall improvement in their quality of life.

Uncompromising Safety

Patient safety is our top priority. Our inhaler devices undergo rigorous testing and adhere to the highest industry standards, ensuring the utmost safety and reliability for users.

Comprehensive Customer Support

We go beyond providing innovative products; we offer comprehensive customer support services to ensure a seamless experience for patients and healthcare providers. Our dedicated support team is readily available to address inquiries and provide assistance as needed.

Why to Buy This Report-

The report provides a qualitative as well as quantitative analysis of the global Respiratory Inhaler Devices Market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2016-2020, the base year- 2021, and the projection period 2022-2028.

The report includes information on the competitive landscape, such as how the market's top competitors operate at the global, regional, and country levels.

Major nations in each region with their import/export statistics

The global Respiratory Inhaler Devices Market report also includes the analysis of the market at a global, regional, and country-level along with key market trends, major players analysis, market growth strategies, and key application areas.

Browse Full Report: https://www.credenceresearch.com/report/respiratory-inhaler-devices-market

Visit: https://www.credenceresearch.com/

Related Report: https://www.credenceresearch.com/report/myocardial-infarction-treatment-market

Related Report: https://www.credenceresearch.com/report/host-cell-contaminant-testing-market

Browse Our Blog: https://www.linkedin.com/pulse/respiratory-inhaler-devices-market-future-growth-prospects-singh

Browse Our Blog: https://medium.com/@priyanshi_97937/respiratory-inhaler-devices-market-analysis-with-size-revenue-growth-drivers-and-forecast-to-2030-46bad0424ba5

About Us -

Credence Research is a viable intelligence and market research platform that provides quantitative B2B research to more than 10,000 clients worldwide and is built on the Give principle. The company is a market research and consulting firm serving governments, non-legislative associations, non-profit organizations, and various organizations worldwide. We help our clients improve their execution in a lasting way and understand their most imperative objectives. For nearly a century, we’ve built a company well-prepared for this task.

Contact Us:

Office No 3 Second Floor, Abhilasha Bhawan, Pinto Park, Gwalior [M.P] 474005 India

[market-insider]

Measured Volume Burette Set Market Report: Emerging Applications and Future Prospects

The global measured volume burette set market size is expected to reach USD 804.7 million by 2030. The burette sets are intended specifically for the gravity-based administration of precise volumes of infusion fluid. Burette sets with a flexible, clear, and calibrated measured volume container are infusion tools used for precise measurement. Burette chamber is scaled for precise medication measurement for treating chronic illness, newborn and pediatric treatment. 

Gain deeper insights on the market and receive your free copy with TOC now @: Measured Volume Burette Set Market Report

The growing global incidence of chronic diseases like cancer and diabetes is driving up demand for measured volumetric burettes. These devices are being adopted by hospitals and other healthcare institutions to provide patients with large volumes of medications and nutrients. Major life sciences and diagnostics companies like Thermo Fisher, B. Braun, Baxter, and others are also expected to support the market's expansion.

During the forecast period, the market is anticipated to be driven by the expanding use of measured volume burettes for paediatric or neonatal treatment. For treating paediatric patients, healthcare centers and other medical establishments commonly use volumetric burette infusion sets. When treating pediatric patients, the burette IV sets, which allow the provider to dispense a precise and controlled quantity of medicine, can be extremely important. Products like Dosifix, a device made available by Braun, are intended for use in treating paediatric and neonatal patients. 

[delvenservices]

Defibrillator Market Size, Share, Demand Analysis: 2028

Defibrillator Market, by Product Type (Implantable Cardioverter Defibrillator and External Defibrillator), Patient Type (Adult, Paediatric), End Users, and Region (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

The global defibrillators market is projected to reach USD 11.4 billion in 2021, at a CAGR of 10.7% from 2021-2028.

Defibrillators are devices used to deliver therapeutic shock to a patient’s heart in life-threatening conditions such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. The defibrillation procedure encompasses delivery of an electric shock to the heart, which depolarizes heart muscles and restores its normal electric impulse.

The rising prevalence of target diseases, growing focus on providing public-access defibrillators, and training and awareness programs on defibrillators are some of the factors that have supported long-term expansion for Defibrillators Market.

Get the Free Sample Now: https://www.delvens.com/get-free-sample/defibrillators-market-trends-forecast-till-2028

Regional Analysis

The Asia Pacific region is expected to register the highest growth during the forecast period. The Asia Pacific is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific, including Malaysia, Taiwan, Singapore, and New Zealand.

Key Players

Asahi Kasei Corporation

Stryker Corporation

Biotronik SE & Co. KG

Boston Scientific Corporation

Philips Healthcare

LivaNova PLC

Medtronic plc

Cardiac Science Corporation

Nihon Kohden Corporation

St. Jude Medical, Inc.

Make an Inquiry Before Buying at: https://www.delvens.com/Inquire-before-buying/defibrillators-market-trends-forecast-till-2028

Recent Developments

In July 2020, Abbott received FDA approval for its next generation ICDs and CRT-Ds under the brand name Gallant.

In June 2020, Koninklijke Philips received FDA pre-market approval for Heart Start FR3 and Heart Start FRX AED

Reasons to Acquire

Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors

Gain authentic and granular data access for Defibrillators Market so as to understand the trends and the factors involved behind changing market situations

Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future

In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Direct Purchase of Research Report at: https://www.delvens.com/checkout/defibrillators-market-trends-forecast-till-2028

Report Scope:

Defibrillators Market is segmented into type, patients’ type, end user and region.

On the basis of Type

Implantable cardioverter defibrillators

Transvenous implantable cardioverter defibrillators

Subcutaneous implantable cardioverter defibrillators

External defibrillators

Manual & semi-automated external defibrillators

Fully automated external defibrillators

Wearable cardioverter defibrillators

On the basis of Patient’s Type  

Adults

Paediatrics

On the basis of End-User  

Implantable cardioverter defibrillators

Transvenous implantable cardioverter defibrillators

Subcutaneous implantable cardioverter defibrillators

External defibrillators

Manual & semi-automated external defibrillators

Fully automated external defibrillators

Wearable cardioverter defibrillators

On the basis of Region

Asia Pacific

North America

Europe

South America

Middle East & Africa

About Us:

Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.

Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.

Contact Us:

UNIT NO. 2126, TOWER B,

21ST FLOOR ALPHATHUM

SECTOR 90 NOIDA 201305, IN

+44-20-8638-5055

SALES@DELVENS.COM

[rohans18]

Gait Trainer Market Expected High Growth in Coming Years

Global Gait Trainer Market, By Application (Orthopaedic Disorders, Neurological Disorders, Amputation, Others), Product Type (Treadmill System, Exoskeleton, Gait Trainer Walker), End Users (Home Care Settings, Rehabilitation Centers, Hospitals), Age Category (Paediatric, Adult), Connectivity (Wired, Wireless), Artificial Intelligence (Offering, Technology) – Industry Trends and Forecast to 2029

An expert team performs systematic, object-oriented and complete market research study to provide the facts associated with any subject in the field of marketing via Gait Trainer marketing report. The report has a lot to offer to both established and new players in the Gait Trainer industry with which they can completely understand the market. SWOT analysis and Porter’s Five Forces analysis methods are used wherever applicable, while generating this report. One of the most important parts of an international Gait Trainer market report is competitor analysis with which businesses can estimate or analyse the strengths and weaknesses of the competitors.

Key Players

Some of the major players operating in the gait trainer market are OTTOBOCK, Ekso Bionics, Rex Bionics Ltd., ReWalk Robotics, Medical Depot, Inc., Rifton Equipment, Hocoma, AlterG, Inc., Biodex, Meyland-Smith A/S, Bharat Medical Systems, Bio-Med Inc., Etac AB., Woodway USA, Inc., and medica Medizintechnik among others.

 Browse More Info @ https://www.databridgemarketresearch.com/reports/global-gait-trainer-market

With the help of credible Gait Trainer market analysis report, businesses can make out the reaction of the consumers to an already existing product in the market. The report includes estimations of recent state of the market, CAGR values, market size and market share, revenue generation, and necessary changes required in the future products. A wide-ranging competitor analysis helps build superior strategies of production, improvement in certain product, its advertising or marketing and promotion for the business. Exhaustive and comprehensive market study performed in the wide ranging Gait Trainer market report offers current and forthcoming opportunities that put light on the future market investment.

Key questions answered in the report:

Which product segment will grab a lion’s share?

Which regional market will emerge as a frontrunner in coming years?

Which application segment will grow at a robust rate?

Report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Gait Trainer Market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Table Of Content

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03:  Global Market

Part 04: Global Market Size

Part 05: Global Market Segmentation By Product

Part 06: Five Forces Analysis

 More Reports:

Nephrology And Urology Devices Market

Artificial Ventilation Market

Gait Trainer Market

Clinical Microbiology Market

Enzyme-Linked Immunospot Assays Market

FluoroSpot Market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: sales@databridgemarketresearch.com

[mmrseo]

Paediatric Medical Device Market is estimated to reach US$ XX Mn by 2026 in terms of revenue at a CAGR of XX % in the forecast Period.

[aprao22]

Top 10 Pharma companies

Top 10 pharmaceutical companies in the world

These are ranked by revenue and market capitalization:

1. Pfizer — $51.8 billion 2. Roche  — $50.1 billion 3. Novartis  — $47.45 billion                                                                                    4. Merck  — $46.9 billion 5. GlaxoSmithKline (GSK) — $43.6 billion 6. Johnson & Johnson (J&J) — $42.2 billion 7. AbbVie — $33.3 billion 8. Sanofi — $27.8 billion 9. Bristol-Myers Squibb — $26.2billion 10. AstraZeneca — $23.6 billion

1.Pfizer

Pfizer is an American multinational pharmaceutical corporation, headquartered in Manhattan. It develops and produces medicines and vaccines for a wide range including oncology, cardiology, neurology, immunology, and endocrinolog

2.Roche

Hoffmann-Roche AG is a Swiss multinational pharmaceutical company headquarters located in Basel, Switzerland.it operates two divisions: Pharmaceuticals and Diagnostics.

3.Novartis

Novartis AG is a Switzerland multinational pharmaceutical company headquarters located in Basel. It manufactures drugs clozapine, diclofenac, carbamazepine, valsartan, terbinafine, and others.

4.Merck

Merck & Co. is a German multinational pharmaceutical company incorporated in Jersey, United States of America.

5. GlaxoSmithKline ( GSK)

GlaxoSmithKline (GSK) is a British multinational pharmaceutical company headquartered in Brantford, England in 2000.

6. Johnson & Johnson (J&J)

Johnson & Johnson (J&J) is an American multinational company headquartered, New Jersey in 1886. It develops medical devices, pharmaceuticals, and consumer goods.

7. AbbVie

AbbVie is an American multinational corporation biopharmaceutical company founded in 2013. It operates as research-based pharmaceutical products, medical devices, diagnostic equipment, and nutrition products

8. Sanofi

Sanofi S.A. is a French multinational pharmaceutical company headquartered in Paris, France, founded in 2013. It operates in the R&D, manufacturing, and pharmaceutical drugs' major therapeutic areas are the cardiovascular, central nervous system, diabetes, internal medicine, oncology, and vaccines.

9. Bristol-Myers Squibb

Bristol Myers Squibb is an American multinational pharmaceutical company, located in New York City. It manufactures pharmaceuticals, biologics, therapeutics, oncology, HIV, cardiovascular, diabetes, hepatitis, arthritis, and psychiatric diseases.

10. AstraZeneca 

AstraZeneca, is a Britain-Swedan multinational biopharmaceutical company, headquarters in England. It has manufactured major disease areas cancer, cardiovascular, respiratory, and inflammation. In 1999. they merged Swedish Astra AB and the British Zeneca Group.

Top 10 pharmaceutical companies in India

The top 10 pharmaceutical companies in India ranked by revenue and market capitalization:

Rank    Industry                        $Billions        ₹Crores

1           Sun Pharma                   10.3              75326.63

2           Dr. Reddy’s                      7.4               54,223.62

3           Divi’s                                6.2               45,023.67

4          Cipla                                 5.3               38,875.43

5          Aurobindo                         4.9               35,641.85

6          Torrent                              4.4               32054.46

7          Lupin                                 4.2               30362.52

8          Zydus Cadila                     3.5               25325.64

9          Abbott India                       3.1               22624.21

10        Alkem                                2.5                18584.54

India is the largest provider of generic medicines, holding a market share of 25% to worldwide supply by volume and meets 61% of the vaccine requirement around the world. Indian pharmaceutical companies also supply 81% of antiretroviral medications (HIV/AIDS) in the worldwide markets.

The international pharmaceutical market is anticipated to surpass USD 1.2Trillion by 2022. India is one most suitable states in this worldwide pharma market. India provides more than 55% of the worldwide purpose for different vaccines and 45% of the demand for generic medicines in the United States. India’s pharmaceuticals demanded to expand at 11% CAGR during 2023 to reach 33 Billion US dollars.

1. Sun Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Ltd is an Indian multinational pharmaceutical company founder Dilip Shanghvi in 1983, Vapi, Headquarters Goregaon, Mumbai, India, And Subsidiaries Ranbaxy Laboratories, etc...It produces and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India also the United States. Sun Pharma provides formulations in psychiatry, cardiology, dialectology, neurology, and gastroenterology. The company supplies APIs such as etodolac, clorazepate, carbamazepine, warfarin, and anti-cancer drugs, peptides, steroids, sex hormones, etc. Sun supplies more than 2000 formulations and also exports in various other countries. The main features of Sun Pharmaceuticals are research and development facilities and its own API’s

2. Dr. Reddy’s Laboratories Ltd

Dr. Reddy’s Laboratories Ltd is an Indian multinational pharmaceutical company founder Kallam Anji Reddy in 1984, Hyderabad, India. The company produces pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and other countries and more than 195 drugs, 65 APIs for drug, biotechnology products. DRL has six APIs(CTO)and four Formulations(FTO)manufacturing plants across India. Its main focus research and development centers are Integrated product development Organization(IPDO) and Custom Pharmaceutical Services(CPS) located in Hyderabad, India.

3.Divi’s Laboratories Ltd

Divis Laboratories Ltd is an Indian pharmaceutical company founder Murali Divi in 1990, Hyderabad, India. It manufactures APIs, Intermediates, and Nutraceutical ingredients. Divis Labs have three manufacturing units located at Chouttal, Hyderabad, Chippada, A. Andhra Pradesh, and 3 Research and development centers. The Company exports the products to the USA, Europe, Japan, South Africa, Australia, and the Philippines.

4. Cipla Ltd

Cipla is an Indian multinational pharmaceutical company founder Khwaja Abdul Hamied in 1935, Headquarters Mumbai, India, And supplies top-quality generic medicines in India The company supplies a wide range of medicines. It has got a prominent position in the Indian market ad global market and more than 150 countries. The company provides quality products worldwide received approvals from major regulatory agencies and more than 2000 formulations cover areas like neurology and nephrology. Cipla has a global focus on the important markets of India, the US, and South Africa.

5.Aurobindo Pharma Ltd

Aurobindo Pharma is an Indian pharmaceutical company founder Nityananda Reddy started operations in 1988 with a single unit manufacturing Synthetic Penicillin at Pondicherry after became a public company in 1992 headquartered in HITEC City, Hyderabad, India. the company has provided key therapeutics like cardiovascular, antiretrovirals, antibiotics, gastroenterology, anti-diabetics, anti-Allergics. The company exports products to more than 160 nations in the world. Aurobindo pharma has production, research, and development and Subsidiaries units are Novagen Pharma, AuroZymes Ltd, etc

6. Torrent Pharmaceuticals Ltd

Torrent Pharma an Indian pharmaceutical company founder Uttambhai NathalalMehta in 1959 Headquarters Ahmedabad, India. started as Trinity Laboratories Ltd, and renamed Torrent Pharmaceuticals Ltd. nowadays, it is ranked leaders in the therapeutic sector of the women’s health care, cardiovascular, CNS, gastrointestinal, diabetology, oncology, gynecology, and anti-infective. They have first-class manufacturing units, R & D facilities, and a prevalent international presence in more than 50 nations. The company had procured the Elder Pharma’s Indian company, Zyg Pharma, the API plant of Glochem Industries, Unichem’s Sikkim Plant, Bio-Pharm Inc, generic pharmaceuticals, etc.

7. Lupin Ltd

Lupin is a multinational pharmaceutical company founder Desh Bandhu Gupta in 1968 Mumbai, India a large range of products like Branded & Generic Formulations, Biotechnology Products, APIs, and manufacturing centers are across India, Japan, Brazil, Mexico, and the United States. Subsidiaries are Novel Laboratories, Polynova Industries, and GAVIS Pharmaceuticals. The company is in treatment areas of Non-Steroidal Anti-Inflammatory Drugs, Cardiovascular, Gynaecology, Asthma, Paediatric, Diabetology, Gastro-Intestinal, and Anti-Infective drugs, Anti-TB and Cephalosporins sectors. The company is moved around more than 100 countries. It supplies top quality medications.

8.Zydus Cadila Healthcare Ltd

Zydus Cadila is a Zydus Cadila, is a fully integrated Indian Pharmaceutical company founded by Ramanbhai B. Patel in 1952 in Ahmedabad, Gujarat India. It provides active pharmaceutical ingredients, formulations, and animal healthcare products to wellness products. The company’s research and development facilities are in Gujarat, Maharashtra, Goa, Himachal, and Sikkim also research units in the US and Brazil. It has 1400 researchers across 20 sites, working on medicines and exploring various ideas from NCEs to vaccines, bio-similar products. The company’s global business has regulated markets of the United States, Europe, South Africa, Latin America, and also 30 other national markets in the world.

9. Abbott Pharma India Ltd

Abbott India Limited is a Pharmaceutical company founder Dr. Wallace Calvin Abbott in 1944, Mumbai, India, and a subsidiary of Abbott Laboratories United States. It manufactures pharmaceutical drugs, therapeutics Women’s Health, Neurology, Thyroid, Gastroenterology, Anti-Infective, Diabetes, Urology, Pain, Vitamins, etc., and a plant at Verna, Goa. Abbott has to produce high-quality formulations, branded generic pharmaceuticals, diagnostics, medical devices, and nutrition.

10. Alkem Laboratories Ltd

Alkem Laboratories is a Pharmaceutical company founder Samprada Singh in 1973, Mumbai, India. It provides quality branded generics, generic medications, APIs, nutraceuticals in India, and more than 60 countries around the world. Alkem Laboratories has been ranked as the No.1 Anti-infective company in India for more than ten years also therapeutic segments of gastrointestinal, Vitamins, Minerals, Nutrients, and pain management.

[supersanuse]

Paediatric Medical Device Market

Paediatric Medical Device Market is estimated to reach US$ XX Mn by 2026 in terms of revenue at a CAGR of XX % in the forecast Period.

The market for Paediatric Medical Device Market is growing tremendously due to a rising incidence of diseases among children, rising child bearing age among women, increasing number of children with chronic heart diseases, the rising number of paediatric hospitals and clinics. Development of health care infrastructure in emerging economies and rise in awareness about the available treatments for paediatric health issues have led to adopt Paediatric Medical Device Market rapidly. Increase in government’s initiatives to fight against malnutrition will also provide ample opportunities for the market to grow in the upcoming years.

 The surge in awareness about paediatric care, economic growth in emerging markets, and technical advancements in the paediatric healthcare industry is expected to augment the global market during the forecast period. However, a lack of significant biocompatibility and safety criteria for the medical devices have restrained the growth of Paediatric Medical Device Market.

 Paediatric Medical Device Market is majorly segmented by type, product, end-user, and region. In terms of product, the neonatal ICU devices segment held major market share in 2017 and is projected to lead the market by 2026. Anesthesia and respiratory devices have a fairly high usage, particularly among paediatric patients, due to their efficacy in treating diseases such as asthma.

 The North America region in the Paediatric Medical Device Market holds a major market share and is predominantly driven by factors such as a rise in prevalence of cancer and respiratory diseases, increase in popularity of portable devices, and growing preference for home healthcare devices and services. In addition, Asia Pacific region is the fastest growing region because of untapped opportunities, improving healthcare infrastructure, increase in awareness about available diagnostic procedures and technologies, and favorable government initiatives.

 Paediatric Medical Device Market share is consolidated, as key multinational players occupy the major industry share. Johnson & Johnson and Abbott are some of the major industry players. Production capacity expansion, brand portfolio expansion, mergers, collaborations, and acquisitions are the key strategies adopted by industry players. Johnson & Johnson are into consumer businesses that embrace innovative science to create medical products, anticipate consumer needs and create experiences that help people to live healthy & vibrant lives.

Report Scope:

 The Paediatric Medical Device Market covered in this report has been segmented as follows:

Paediatric Medical Device Market, By Type

 • Infant Caps

• Infant Incubators

• Bili Lights

• New Born Hearing Screener

• Infant Warmer

• Cranial Orthosis

• Atrial Septal Defect Occlude

• Cerebrospinal Fluid Shunt

• Others

• Pulse Oximeter For Infants

• Automated External Defibrillator

Paediatric Medical Device Market, By Product

 • In Vitro Diagnostic (IVD) Devices

• Cardiology Devices

• Diagnostic Imaging Devices

• Anaesthesia & Respiratory Care Devices

• Neonatal ICU Devices

• Monitoring Devices Telemedicine

• Home-use Medical Devices

Paediatric Medical Device Market, By End User

 • Hospitals

• Paediatric Clinics

• Others

Paediatric Medical Device Market, By Region

 • North America

• Europe

• Asia-Pacific

• Middle East & Africa

• Latin America

Key Players operating in the Paediatric Medical Device Market:

 • Abbott

• General Electric Company

• Johnson & Johnson Private Limited

• Medtronic (Ireland), Siemens AG

• Koninklijke Philips N.V.

• Novamed

• Phoenix Medical Systems

• Phoenix Medical Systems (P) Ltd.

• Pega Medical

Customization of the report:

Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

About Maximize Market Research:

Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Lumawant Godage

Organization Address: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Address : Pune, Maharashtra 411051, India.

Contact: +919607195908      

[foresightintl]

ICARE TA01 Tonometer: Handheld device

The original Icare® tonometer works on a tried-and-true precise measurement principle: a very light probe makes brief, sensitive contact with the cornea.

Not only does the technology make IOP testing more enjoyable for all patients, but it also represents a huge advancement in dealing with non-compliant patients (e.g. children and dementia patients).

The ICARE TA01 Tonometer is iCare's first rebound tonometer for the global market. For a trustworthy basic gadget, the original iCare tonometer is the best option. It is a useful gadget for general practitioners, optometrists, occupational health care, pharmacists, and other medical staff due to its simplicity. It can be used in clinics for adult and paediatric readings, as well as in the field for mass glaucoma tests.

1.Ideal for glaucoma screenings anywhere

IOP measurement is quick and easy for screening programmes and humanitarian missions all around the world because it does not require drops or specialised training.

2.Savings in both time and money

Because the technology does not require calibration, it saves time and money in terms of maintenance and service. Furthermore, rather than concentrating on the device's settings between eyes or patients, eye care practitioners can focus on taking readings.

Even the most difficult patients, such as youngsters or dementia patients, can benefit from the ICARE TA01 Tonometer which gives accurate, objective IOP measurements. IOP can be measured using the iCare TA01i while the patient is sitting or standing.

The ICARE TA01 Tonometer is built to last. It does not require calibration, so it does not require time-consuming maintenance. The deployment of the device requires minimum training, making it appropriate for a wide spectrum of healthcare personnel, from doctors to technicians. The ICARE TA01 Tonometer is extremely cost-effective..

To eliminate corneal disturbances and patient discomfort, the TA01i, like all iCare tonometers, features innovative rebound technology. Without the use of local anaesthesia, the revolutionary rebound approach enables for painless and hygienic IOP monitoring. The patient is unafraid to use the iCare tonometer on the other eye.